Search results
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
The AstraZeneca R&D facility in Gothenburg, Sweden The new AstraZeneca Corporate HQ under construction in Cambridge, England. AstraZeneca develops, manufactures and sells pharmaceutical and biotechnology products to treat disorders in the oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation areas.
Our company. We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
4 days ago · AstraZeneca today announced the successful completion of the acquisition of Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases.. The acquisition bolsters the Alexion, AstraZeneca Rare Disease late-stage pipeline and expands on its bone metabolism franchise with the notable addition of eneboparatide (AZP-3601), a Phase III investigational therapeutic peptide with a novel mechanism of action designed to meet key therapeutic ...
AstraZeneca | 2,937,651 followers on LinkedIn. What science can do | We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the...
At AstraZeneca we’re united by our desire to push the boundaries of science to deliver life-changing medicines. We know it’s how we will continue to transform the lives of millions of patients around the world while delivering value to our employees, our communities, and the environment.
Introducing AstraZeneca's Board of Directors, Senior Executives and Lead Scientists. Find information on each individual membership of the leadership team. Skip to content
Jun 13, 2022 · The AstraZeneca vaccine has an efficacy of 72% against symptomatic SARS-CoV-2 infection, as shown by the primary analysis of data irrespective of interdose interval from trial participants who received 2 standard doses with an interval varying from about 4 to 12 weeks.
We are the leading BioPharmaceutical company in the UK. Across our work in R&D, manufacturing, and our commercial business, we are inspired by what science can do and are on a mission to deliver life-changing medicines, transform population health outcomes and ultimately, accelerate the UK as a global leader in life sciences.
Apr 6, 2022 · AstraZeneca’s Global Technology Centre in India increases its focus on driving innovation – repositioning itself as a Global Innovation and Technology Centre. PUBLISHED 6 April 2022. Chennai, April 6, 2022: AstraZeneca India Private Limited (AZIPL), the Global Capability Centre (GCC) of AstraZeneca announced today that they have ...
